doorgaan naar inhoud
Endocannabinoid regulation of monoamines in psychiatric and neurological disorders Voorbeeldweergave van dit item
SluitenVoorbeeldweergave van dit item
Bezig met controle...

Endocannabinoid regulation of monoamines in psychiatric and neurological disorders

Auteur: Elisabeth J van Bockstaele
Uitgever: New York : Springer, ©2013.
Editie/Formaat:   eBoek : Document : EngelsAlle edities en materiaalsoorten bekijken.
Database:WorldCat
Samenvatting:
The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing  Meer lezen...
Beoordeling:

(nog niet beoordeeld) 0 met beoordelingen - U bent de eerste

Onderwerpen
Meer in deze trant

 

Zoeken naar een online exemplaar

Links naar dit item

Zoeken naar een in de bibliotheek beschikbaar exemplaar

&AllPage.SpinnerRetrieving; Bibliotheken met dit item worden gezocht…

Details

Genre/Vorm: Electronic books
therapeutic use
drug therapy
Aanvullende fysieke materiaalsoort: Print version:
Endocannabinoid regulation of monoamines in psychiatric.
[S.l.] : Springer-Verlag New York, 2013
(OCoLC)841520677
Genre: Document, Internetbron
Soort document: Internetbron, Computerbestand
Alle auteurs / medewerkers: Elisabeth J van Bockstaele
ISBN: 9781461479406 1461479401
OCLC-nummer: 852471079
Opmerkingen: Includes index.
Beschrijving: 1 online resource.
Inhoud: Endocannabinoids and monoamines: modulating the modulators --
Endocannabinoid-mediated synaptic plasticity --
Current cannabinoid receptor nomenclature and pharmacological principles --
Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction --
Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders --
Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers --
Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion --
Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function --
Endocannabinoids, Monoamines and Stress --
Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders --
Endocannabinoid Signaling and the Regulation of the Serotonin System --
Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors --
Involvement of serotonergic system in cannabinoid analgesia --
Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.
Verantwoordelijkheid: Elisabeth J. van Bockstaele, editor.
Meer informatie:

Fragment:

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders  Meer lezen...

Beoordelingen

Professionele beoordelingen

Synopsis uitgever

From the reviews: "This book reviews the expansion of our understanding of cannabinoid modulation of monoaminergic circuits and their interactions in a variety of psychiatric and neurological Meer lezen...

 
Beoordelingen door gebruikers
Beoordelingen van GoodReads worden opgehaald...
Bezig met opvragen DOGObooks-reviews...

Tags

U bent de eerste.
Bevestig deze aanvraag

Misschien heeft u dit item reeds aangevraagd. Selecteer a.u.b. Ok als u toch wilt doorgaan met deze aanvraag.

Gekoppelde data


<http://www.worldcat.org/oclc/852471079>
library:oclcnum"852471079"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/852471079>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing evidence from preclinical data suggesting that therapeutic use of cannabinoid-based drugs may outweigh any potential risks in certain serious medical conditions, the debate surrounding its widespread utility continues as regulatory concerns preclude a smooth transition of promising preclinical studies into clinical trial testing. This may persist in the near future as state and federal governments debate over regulation of medicinal applications of cannabis. Applications for medicinal cannabinoids that are already under investigation include the treatment of nausea, anorexia, neurodegeneration, inflammation, excitotoxicity and pain. The appetitive and anti-emetic properties of cannabinoids have led to the approval of their use in chemotherapy and AIDS patients. There is growing evidence for therapeutic cannabinoid effects on inflammatory and excitotoxic cellular processes that are linked to epilepsy, Parkinson's disease, amyotrophic lateral sclerosis, spasticity, and central nervous system injury. The chapters, herein, review and discuss current insights into the brain endocannabinoid system, cannabinoid receptor signaling on synaptic plasticity, potential therapeutic applications with a particular focus on endocannabinoid modulation of dopaminergic, noradrenergic and serotonergic circuitry. The potential for establishing cannabinoid-monoaminergic interactions as a novel target in the development of improved treatment strategies for psychiatric and neurological disorders is promising and will require future clinical studies to determine whether promising pre-clinical findings translate into new therapies."
schema:description"Endocannabinoids and monoamines: modulating the modulators -- Endocannabinoid-mediated synaptic plasticity -- Current cannabinoid receptor nomenclature and pharmacological principles -- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction -- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders -- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers -- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion -- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function -- Endocannabinoids, Monoamines and Stress -- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders -- Endocannabinoid Signaling and the Regulation of the Serotonin System -- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors -- Involvement of serotonergic system in cannabinoid analgesia -- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis."
schema:exampleOfWork<http://worldcat.org/entity/work/id/1411312578>
schema:genre"Electronic books."
schema:inLanguage"en"
schema:name"Endocannabinoid regulation of monoamines in psychiatric and neurological disorders"
schema:publisher
schema:url<http://site.ebrary.com/id/10733550>
schema:url<http://dx.doi.org/10.1007/978-1-4614-7940-6>
schema:url
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=606343>
schema:url<http://lib.myilibrary.com?id=517034>
schema:workExample

Content-negotiable representations

Venster sluiten

Meld u aan bij WorldCat 

Heeft u geen account? U kunt eenvoudig een nieuwe gratis account aanmaken.